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ABSTRACT 
This article discusses MUM, a knowledge-based consultation system designed to 
manage the uncertainty inherent in medical diagnosis. The primary task of the 
system is to plan which questions, tests, and treatments oorder at each point in a 
consultation, given current uncertain knowledge about the patient's disease. 
Managing uncertainty means planning what to do when uncertain; the authors 
suggest hat this ability must be designed in, not added on, to the architectures of 
knowledge-based ystems. MUM is based on one such architecture, implemented as 
a generalized inference network and planner. The network facilitates local 
combination of evidence; the planner "reads" the state of the network after each 
piece of evidence integrated, then decides which evidence to seek on the basis of its 
several goals. 
KEYWORDS: automated reasoning, diagnosis, planning, control, reason- 
ing about uncertainty 
INTRODUCTION 
MUM (Management of Uncertainty in Medicine) is a knowledge-based 
consultation system designed to manage the uncertainty inherent in medical 
* This research is funded by a grant from the National Science Foundation, IST 8409623, and 
DARPA-RADC Contract, F30602-85-C-0014. The authors gratefully acknowledge the many 
contributions of Thomas Gruber to the MUM Project. 
Address correspondence to Paul Cohen, Experimental Knowledge Systems Laboratory, 
University of Massachusetts, Amherst, Massachusetts 01003. 
International Journal of Approximate Reasoning 1987; 1 : 103- I 16 
© 1987 Elsevier Science Publishing Co., Inc. 
52 Vanderbilt Ave., New York, NY 10017 0888-613X/87/$3.50 103 
104 Paul Cohen et al 
diagnosis. Managing uncertainty means planning actions to minimize uncer- 
tainty or its consequences. Thus, it is a control problem--an issue for the 
component of a knowledge system that decides how to proceed from an 
uncertain state of a problem. 
Uncertainty can be managed by many strategies, depending on the kind of 
problem one is trying to solve. These include asking for evidence, hedging one's 
bets, deciding arbitrarily and backtracking on failure, diversification or risk 
sharing, and worst-case analysis. The facility with which a consultation system 
such as MUM manages uncertainty is evident in the questions it asks: it should 
ask all necessary questions and no unnecessary questions, and it should ask its 
questions in the right order. These conditions, especially the last one, preclude 
uniform and inflexible control strategies. They prompted the development of the 
MUM architecture, in which control decisions are taken by reasoning about 
features of evidence and sources of uncertainty. 
The Goals of MUM 
MUM diagnoses diseases that manifest as chest pain and abdominal pain. This 
involves taking a history, asking for physical findings, ordering tests, and 
prescribing trial therapy. Physicians call a diagnostic sequence of questions and 
tests a workup. MUM's primary goal is to generate workups for chest and 
abdominal diseases that include, in the correct order, all necessary questions and 
tests and none that are superfluous. Because we built MUM to study the 
management of uncertainty, the goal of correct diagnosis is secondary to 
generating the correct workup. We were influenced by a distinction physicians 
make between retrospective diagnosis, in which all evidence is known in 
advance and the goal is to make a correct diagnosis, and prospective diagnosis, 
which emphasizes the workup and proper management of the patient, even under 
uncertainty about his or her condition. MUM is definitely prospective. 
Figure 1 illustrates part of the workup for coronary artery disease. Clearly, 
we could build a system that follows this and other stored workups, but the point 
of the research is to be able to reason about he features of evidence, and the 
uncertainty in partially developed iagnoses, to decide which questions to ask 
next. If MUM does this properly, its questioning will correspond with a standard 
workup or at least be a reasonable alternative workup. 
Managing Uncertainty and Control 
MUM is based on the idea that managing uncertainty and controlling a 
complex knowledge system are manifestations of a single task, namely, 
acquiring evidence and using it to solve problems. There would be little basis for 
variation in problem-solving strategies if all evidence was equally costly, 
reliable, available, and pertinent; but if evidence isdifferentiated along these and 
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other dimensions, then problem solving can be guided by the ideal of maximum 
evidence for minimum cost. For example, here is a strategy for focusing 
attention on available vidence: 
CONTEXT: To minimize cost 
CONDITIONS: Tesh and test2 are pertinent, and 
tesh is potentially-confirming, and 
test2 is potentially-supporting, and 
cost(tesh) >> cost(test2) 
ACTIONS: Begin 
Do test2 
If supporting then do tesh, 
else do not do tesh 
End 
That is, according to this strategy, given cheap, weak evidence and expensive, 
strong evidence, one should acquire the weak evidence first and not incur the 
cost of the strong evidence unless the weak evidence l nds support. The rule thus 
serves to manage the uncertainty associated with the weak evidence. It also uses 
features of evidence such as cost and reliability to control the acquisition of 
evidence; for example, it explains why an angiogram--an expensive, risky, and 
painful test--is done only after a stress test (see Figure 1). We distinguish these 
functions--managing uncertainty and control--only because uncertainty and 
control have, with a few exceptions (noted below), been viewed as different 
topics. In fact, if control decisions are based on features of evidence, then 
control and managing uncertainty are the same thing. This is the principle that 
motivates the design of MUM. 
Related Work 
The close association between control and managing uncertainty has been 
apparent in the literature on sophisticated control for several years* but is largely 
absent from the artificial intelligence (AI) literature on reasoning under 
uncertainty. Three important results have emerged from research on control. 
First, complex and uncertain problems have to be solved opportunistically and 
asynchronously--working o  subproblems in an order dictated by the availabil- 
ity and quality of evidence (Hayes-Roth and Lesser [7]). Second, as control 
tends to be accomplished by local decisions about focus of attention, the 
behavior of complex knowledge systems ometimes lacks global coherence. 
Coherence can be achieved by planning sequences of actions instead of selecting 
individual actions by local criteria. * Third, programs are impossible to 
* See, for example, the classic paper by Erman, L., Hayes-Roth, F., Lesser, V., and Red@, D., 
The Hearsay-lI Speech Understanding System: Integrating Knowledge to Resolve Uncertainty, 
Computing Surveys 12(2), 213-253, 1980. 
t Personal communication, Victor Lesser. 
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understand if the factors that affect control decisions are implicit. For example, 
the focus of attention in Hearsay-II was difficult to follow because it depended 
on many numerical parameters calculated from data and combined by empirical 
functions with "tuning" parameters [7]. A better approach is to explicitly state 
and reason about he implicit factors, called control parameters (Wesley [12]), 
which the numbers represent (Davis [4], Clancey [2]). If the control parameters 
are features of evidence and uncertainty, then control strategies can be 
developed to manage uncertainty. 
This last point colors our reading of the AI literature on reasoning under 
uncertainty. Much of it is concerned with the mathematics of combining 
evidence, the calculation of degrees of belief in hypotheses. (A representative 
sample includes Shortliffe and Buchanan [10], Duda, Hart, and Nilsson [51, 
Zadeh [13], and Shafer [9]. See Cohen and Gruber [3] and Bonissone [1] for 
literature reviews, including non-numeric approaches to uncertainty; and 
Szolovits and Pauker [11] for a discussion of uncertainty in medicine.) Degrees 
of belief can serve as control parameters, but it is necessary to maintain a 
distinction between combining evidence and control. Otherwise, degrees of 
belief (and the functions that combine them) have to be "tuned" not only to find 
the most likely answer but also to focus attention i  a reasonable way. Inevitably 
they become ambiguous summaries of implicit control parameters. For example, 
MYCIN's certainty factors contained probabilistic and salience information, an 
indirect result of using them to focus attention (Shortliffe and Buchanan [10]). 
Another important reason to maintain the distinction between combining 
evidence and control is that combining evidence is only a part of the problem of 
reasoning under uncertainty. Other aspects include formulating decisions, 
assessing the need for more evidence, planning how to get it, deciding whether it
is worth the cost and, if it is not, hedging against residual uncertainty. In MUM 
we address the problem of combining uncertainty in the context of these other 
tasks. 
AN ARCHITECTURE FOR MANAGING UNCERTAINTY 
Managing uncertainty in MUM requires everal kinds of knowledge that are 
discussed in this section. Anticipating the section on control, we find it useful to 
think of data moving bottom up through Figure 2 as they trigger hypotheses and 
are requested by MUM's planner. 
Types of Knowledge 
DATA, EVIDENCE, AND INTERPRETATION FUNCTIONS Evidence is abstracted 
from data through interpretation functions. All data about a patient are stored in 
frames that describe personal history, family history, test results, history of 
108 Paul Cohen et al 
Disease - 1 
Triggering Condition: 
IF (supported Cluster-4) 
Combining-function: 
IF (and (supported Cluster-2) 
(confirmed Cluster-4)) 
THEN strongly-supported 
IF (confirmed Cluster-t) 
THEN detracted 
I 
Disease - 2 
Triggering-Condition: 
IF (supported (duster-7)) 
Combining Function: 
IF (supported Cluster-4) 
THEN supported 
IF (supported Cluster-2) 
THEN supported 
IF (and (supported Cluster-4) 
(supported CJuster-2) 
THEN ~-suppoaed 
(" Cluster - 1 ~ | Cluster - 2 / 
] Combininn Function" / /Combining-Function: / 
"'=~ " • IF (confirmed Evidence-4) I ,F (and (supported Evidence-I) / / / 
(nonsmoker Evidence-2)) . . . . . . . . . . . .  
i . . . . . . . . . .  " " - - _ " : : -  J I THEN c~r~,:~ I 
/ 
"l~nte rprEt:d:: cF: ncllio n: ~ 
J Datum - 1 
Data Acquisition Routine: . . . .  
Figure 2. 
f -  Evidence - 2 ~'~ ',. 
Interpretation Function: "" 
IF (equal smoker 
>2 packs : heavy-smoker 
I-2 packs : mod-smoker 
<1 pack : 6ght-smoker 
0 packs :non-smoker) 
. . . .  i~otenBal-6ata-- [- ~-- "~ 
I 
Knowledge Structures in MUM 
\ *°% 
episodes, and other information. Interpretation functions map data to evidence; 
for example, information that a patient smokes three packs of cigarettes a day is 
abstracted tothe evidence heavy smoker by an interpretation function that maps 
data about smoking habits to one of the following: nonsmoker, light smoker, 
moderate smoker, heavy smoker. Interpretation functions are often graphs called 
belief curves that relate ranges of a continuous data variable to belief in 
evidence. Figure 3 shows a belief curve relating the duration of chest pain to the 
evidence classic anginal pain. 
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Figure 3. Belief Curve Plotting the Datum "Duration of Pain in Minutes" versus Belief 
in the Evidence "Classic Anginal Pain" 
Belief curves and other interpretation functions are acquired from an expert. 
They provide the same functionality as Zadeh's fuzzy predicates [13] and 
generalize Clancey's view of data abstraction as categorical [2]. 
FEATURES OF EVIDENCE Evidence may be characterized by its cost, 
reliability, and roles. The cost of evidence reflects monetary cost as well as 
discomfort and risk to the patient (later versions of MUM will separate these and 
other determinants of cost). Reliability refers to several factors, including 
false-positive and miss rates of tests, and also the belief in evidence derived from 
belief curves (e.g., Is classic anginal pain at least supported by data about the 
pain duration?). 
The most important feature of evidence is the roles it can play with respect to 
evaluating hypotheses. MUM recognizes five roles, two of which are symmetric 
pairs. 
1. Potentially confirming and potentially disconfirming. If evidence plays 
a potentially confirming role with respect to a hypothesis, then acquiring it 
might confirm the hypothesis, although not all potentially confirming 
evidence will in actuality confirm. For example, an EKG confirms the 
hypothesis of angina only if "positive" (i.e., showing ischemic hanges). 
Once confirmed (or disconfirmed), a hypothesis requires no further 
evidence, although a diagnostician may continue working to disconfirm 
other hypotheses, especially if they are dangerous. 
2. Potentially supporting and potentially detracting. Such evidence is like 
potentially confirming and potentially disconfirming, but not conclusive. 
However, combinations of supporting or detracting evidence may be 
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confirming and disconfirming, respectively (see "Combining Functions," 
below). The combination referred to as cluster-2 (Figure 2) is potentially 
supporting with respect o disease-2; cluster-1 is potentially detracting 
with respect o disease-1. 
3. Trigger. Evidence plays the triggering role with respect to a hypothesis f
its presence focuses attention on the hypothesis or "brings the hypothesis 
to mind," or, in MUM, adds the hypothesis to a list of potential diagnoses. 
Cluster-4, if it is supported, triggers disease-1 (Figure 2). This role of 
evidence is found in virtually all medical expert systems. 
4. Modifying. Some evidence primarily alters the way diagnosis proceeds. 
For example, risk factors for coronary artery disease (e.g., hypertension, 
elevated cholesterol) play a modifying role with respect to the hypothesis 
of angina, as the diagnosis will proceed aggressively if they are present 
and less aggressively otherwise. 
Note that evidence can play multiple roles with respect to any 
hypothesis; for example, risk factors are both potentially supporting and 
modifying with respect to angina; and most triggers are individually or in 
combination with other evidence at least potentially supporting (e.g., note 
the roles cluster-4 plays with respect o disease-1 in Figure 2). Also, one 
piece of evidence can play different roles with respect to several 
hypotheses (illustrated by the roles cluster-2 plays with respect to disease-1 
and disease-2 in Figure 2). Finally, note that some evidence potentially 
plays two symmetric roles, whereas ome is "asymmetric"; for example, a
stress test will either support coronary artery disease or detract from it, 
whereas an EKG supports angina if it is positive and is useless otherwise. 
That is, EKG plays a potentially supporting role only. 
5. Clusters. Physicians often see collections of evidence that play particular 
roles in diagnosis; for example, shortness of breath that comes on suddenly 
but is unrelated to exercise (or other inciting factors) triggers the diagnosis 
of pulmonary embolism. Just as evidence has roles with respect to clusters, 
so clusters have roles with respect to diseases, and these roles need not be 
supporting; for example, the cluster (patient age < 30 and no family 
history of coronary events) plays a potentially disconfirming role with 
respect to all coronary diagnoses of chest pain. Instead of saying that the 
available vidence is a poor match to coronary diagnoses, we can say the 
evidence is a good match to a cluster that potentially detracts from or 
disconfirms coronary diagnoses. 
COMBINING FUNCTIONS Every cluster includes a function, specified by the 
expert, that combines the available vidence for the cluster and returns a value 
for the cluster-given evidence. The values returned by combining functions are 
just "realizations" of potential roles of evidence. For example, the value 
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returned by the combining function of a cluster supported by potentially 
confirming evidence could be confirmed. The value for a cluster with several 
pieces of potentially detracting evidence might be disconfirmed or perhaps 
detracted. (Combining functions are further discussed below.) 
DISEASES A disease is technically a cluster. Diseases reside at the top of a 
hierarchy of clusters (as shown in Figure 2), each of which has its own 
combining function and specifications of the roles played by the clusters 
below it. 
STRATEGIC KNOWLEDGE We characterize strategic knowledge as heuristics 
for deciding which triggered isease hypotheses tofocus on and how to go about 
selecting actions to gather evidence pertinent o these hypotheses. These 
heuristics have the same contingent nature as Davis' meta-rules [4] and control 
rules in Neomycin (Clancey [2]). We represent strategies as rules that include: 
Conditions for selection of the strategy. 
A focus policy that guides the choice of a subset of the triggered isease 
hypotheses tofocus on. 
Planning criteria that guide the selection of actions to gather evidence 
and treat diseases currently in the focus. 
Examples of focus policies are plausibility (choosing hypotheses on the basis 
of their degree of support); criticality (focusing on hypotheses that, if true, 
would require immediate action); and differentiation (focusing on hypotheses that 
offer alternative explanations for the symptoms). Examples of planning criteria 
are cost (evidence that is easy to obtain and inexpensive on some cost metric, 
such as money and time, is preferable); roles (potentially confirming roles are 
preferred over potentially supporting ones); and diagnosticity (agiven result has 
the potential to increase the belief in one hypothesis and decrease belief in the 
other, as indicated by belief curves). 
Combining Evidence and Propagating Belief 
In MUM evidence is combined by local functions, as shown in Figure 2. 
Typically, knowledge systems require three functions to combine vidence and 
propagate belief. These are illustrated in the context of two inference rules: 
RI: (A AND B)~C 
R2: (D AND E)--, C 
One function calculates the degree of belief (dob) in a conjunction from degrees 
of belief in the conjuncts: 
dob (AND A B)=Fl (dob (A), dob (B)) 
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The second function calculates the degree of belief in a conclusion from the 
degree of belief in its premise (computed by F~) and the "conditional" degree of 
belief in the conclusion given the premise, often called the degree of belief in the 
inference rule: 
dob (CR1)=F2(dob (AND A B), dob (CI(AND A B))) 
The third increases the degree of belief in a conclusion when it is derived by 
independent inferences: 
dob (CRI~RE)=F3(dob (CRI), dob (CR2)) 
In MUM these three kinds of combining are maintained, but with two 
important differences. First, there are no global functions corresponding toF1, 
F2, and F3; all combining is done by functions local to clusters. Second, instead 
of the usual numeric degrees of belief, MUM has seven levels of belief: 
disconfirmed, strongly detracted, etracted, unknown, supported, strongly 
supported, confirmed. These are "realizations" of the roles of evidence 
described earlier. 
Combining evidence and propagating belief in MUM is illustrated in Figure 2. 
Each cluster, including diseases, has its own local combining function, specified 
by an expert. For example, cluster-1 is strongly supported if evidence-1 is 
supported and if the data on a patient's moking habits support evidence that he 
or she is a nonsmoker. This is a conjunction of evidence of the kind calculated by 
Fl above. Another example is found in the combining function for disease-1. If 
cluster-2 and cluster-4 are both confirmed, then disease-1 is strongly supported. 
This illustrates the kind of combining for which F2 above is required: even when 
the evidence for a disease is itself certain, the conditional belief in the disease 
given the evidence may not be certain. Disease-2 also contains a conjunctive 
rule, but the entire combining function illustrates the corroborative situation for 
which F3 is needed. In this case, cluster-4 and cluster-2 individually play 
potentially supporting roles and taken together increase the level of belief in 
disease-2 to strongly supporting. 
Local combining functions have many advantages. Foremost among them is 
the ease with which an expert can specify precisely how the level of belief in a 
cluster depends on the levels of belief in the evidence for that cluster. Control of 
combining evidence is not relinquished to an algorithm but is acquired from the 
expert as part of his or her expertise. Because local combining functions are 
specific to clusters, they can be changed independently. And because the values 
passed between them in MUM are few, it is easy to trace back the derivation of a 
level of belief and pinpoint a faulty local combining function. The prospect of 
having to acquire many functions eems daunting, but we have found it easy and 
intuitive, and much easier to explain than a global numeric method. 
Management of Uncertainty in Medicine 113 
Control of Diagnosis in MUM 
MUM's basic control strategy involves three components. The user interface 
uses data description frames in the knowledge base to ask questions and create 
patient data frames for the results. The matcher uses the interpretation and 
combining functions to record the effect that incoming data have on the belief 
states for clusters and disease frames, and triggers new hypotheses as 
appropriate. Finally, the planner uses strategic control rules to guide the 
selection of a focus set and the planning process. 
BASIC CONTROL The planner follows a basic control loop within which it 
interprets strategic ontrol rules. It is implemented in a blackboard system with 
knowledge sources pecified in the same syntax as strategic ontrol rules. This 
facilitates experimental modifications. The design of the blackboard system was 
influenced by Hayes-Roth [6] and shares the emphasis on explicit solution to the 
control problem. We first describe the basic control oop, then strategies and 
their selection. 
The basic control loop is initiated with the choice of a strategic phase. All 
strategic phases but one include a focus policy that directs MUM's attention to a 
subset of candidate hypotheses. This is followed by the selection of short-term 
plans to gather evidence and select reatment pertinent to these hypotheses (the 
rule in the Introduction represents such a plan). Because the effort of developing 
lengthy plans may well be wasted in a domain permeated with uncertainty, we 
constrain plans to single actions or sequences of two actions, where the 
applicability of the second depends on the outcome of the first. Several 
short-range plans may be generated and executed. 
Carrying out plans typically involves invoking the user interface to request 
some information, updating the status of the diseases with the matcher, and 
conditional continuation of the plan. When no short-term plans remain, the 
system iterates the basic control oop to determine if a new strategic phase is 
appropriate, updates the focus, and generates new short-term plans. 
STRATEGIC CONTROL We represent MUM's overall strategy as an ordered set 
of rule-like strategic phases, shown in Figure 4. Each phase has conditions that 
activate it. Once activated, a phase controls MUM's focus of attention and the 
choice of actions pertaining to the hypotheses in this focus. 
The phase Get General Picture is invoked when the system is started and may 
also be used if all previously considered hypotheses are ruled out. It has no focus 
policy because no hypotheses are active when it is invoked. It directs the planner 
to ask for evidence that plays the potential trigger role for one or more 
hypotheses, pursuing the lowest-cost evidence first. The cluster initial 
consultation (consisting of age, sex, and primary complaint) meets the criteria 
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Strategic Phase: 
Conditions: 
Focus Policy: 
Planning Criteria: 
Strategic Phase: 
Conditions: 
Focus Policy: 
Planning Criteria: 
Strategic Phase: 
Conditions: 
Focus Policy: 
Planning Criteria: 
Strategic Phase: 
Conditions: 
Focus Policy: 
Planning Criteria: 
Figure 4. 
Get General Picture. 
No candidate hypotheses. 
None. 
Evidence must play trigger role; prefer 
low cost on all cost metrics. 
Initial Assessment for Triggered Hypotheses. 
One or more hypotheses are triggered. 
Focus on triggered hypotheses. 
Must be low on all cost metrics; prefer 
stronger oles. 
Deal With Critical Possibilities. 
There are critical hypotheses that 
have not been confirmed, disconfirmed, or 
strongly detracted; if they are detracted, 
no other hypothesis i confirmed. 
Criticality. 
Rule out if possible, else gather support. 
Utility of evidence. Low cost first; as 
needed, let discomfort and monetary cost 
increase. 
Discriminate Strongest Hypotheses. 
More than one hypothesis i supported. 
Plausibility. 
Diagnosticity. Low cost first. Utility of 
evidence. Substitute high-cost confirmation 
for one hypothesis with lower-cost 
disconfirmation for the other. 
Four Strategic Phases in MUM's Diagnosis 
of potentially triggering many hypotheses and costing little. The initial 
consultation usually triggers ome hypotheses, which result in selection of a new 
strategic phase. I f  no hypotheses are triggered, the planner asks for potential 
triggers of higher cost. 
The Initial Assessment for Triggered Hypotheses phase is invoked when 
new hypotheses are triggered. Because the conditions of the other strategic 
phases depend somewhat on the level of belief in candidate hypotheses, this 
phase gathers preliminary evidence for the hypotheses. The focus is on the 
triggered hypotheses, so only evidence playing some role relative to these 
hypotheses i considered by the planner. This phase directs the planner to gather 
low-cost evidence for the hypotheses. For example, MUM asks about aspects of 
the patient's episode (the primary complaint event) that bear on the triggered 
hypothesis, and about risk factors. 
As soon as the easy questions for triggered hypotheses have been asked, 
MUM decides between the next two phases on the basis of its belief in the 
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hypotheses and whether any of the hypotheses are critical, that is, require 
immediate treatment if supported. Critical hypotheses are dealt with first. 
The Deal With Critical Hypotheses phase places all candidate critical 
hypotheses in MUM's focus. The short-range planner is then directed to attempt 
to rule out these hypotheses. It begins with potentially disconfirming or 
potentially detracting evidence. If it fails to find any, then it looks for potentially 
supporting evidence. It will not seek evidence that plays a lesser potential role 
than evidence it already has. For example, itwill not seek potentially supporting 
evidence for a hypothesis that is already strongly supported, but rather focuses 
on potentially confirming evidence. The planner will focus on low-cost evidence 
first, but it is not prohibited from pursuing high-cost evidence as it was in the 
previous phase. 
If the focus of attention is not captured by critical hypotheses, it is dictated 
by plausibility. The strategic phase Discriminate Strongest Hypotheses dis- 
criminates among competing alternatives with as little cost to the patient as 
possible. As before, the potential roles of evidence are used to decide whether it 
is worth acquiring. 
Currently, MUM stops work when a hypothesis confirmed and no critical 
hypotheses remain in its focus. We are implementing the next strategic phases, 
prognosis and treatment. Both provide evidence of diagnostic significance; for 
example, MUM may begin treatment for angina if it is strongly supported rather 
than incur the cost of absolute confirmation. If the treatment relieves the 
symptoms, then it is additional evidence for the diagnosis. If not, it is evidence 
that detracts from the diagnosis and may support others. Because treatment 
provides evidence, we represent treatments a clusters, exactly the same way as 
we represent tests such as angiography. 
CONCLUSIONS 
MUM manages uncertainty by reasoning about evidence and its current state 
of belief in hypotheses. Its goal is to generate appropriate workups for chest and 
abdominal pain. The emphasis in MUM is on asking the right questions in the 
right order without superfluous questions. MUM's control knowledge is not yet 
sophisticated nough to satisfy all these criteria. It asks questions in a reasonable 
order, but it sometimes focuses on the wrong disease. Because MUM is a 
nascent system, this does not yet concern us. We believe the system is successful 
in providing a framework for exploring management of uncertainty by 
sophisticated control--that is, by making control decisions based on the roles, 
costs, and other characteristics of evidence; the criticality of diseases; and the 
credibility of diagnoses. 
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Much work remains to be done. Currently, MUM resembles a programming 
environment more than a medical expert system. We will be devoting ourselves 
to building up its clusters and control rules. 
Although MUM was designed for medical problems and is discussed in that 
context, we believe the approach to uncertainty and control it engenders is 
general to classification problem solvers as well as to other systems responsible 
for the management of uncertainty. An empty version of MUM called MU is 
being developed and will be tested in other domains. 
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